IKARIA^® TO PRESENT AT 2011 BIO INVESTOR FORUM

October 18, 2011 Read more

IKARIA^® NAMES NEW CHIEF FINANCIAL OFFICER

October 11, 2011 Read more

IKARIA^® CEO DANIEL TASSÉ ELECTED TO PhRMA BOARD OF DIRECTORS

September 22, 2011 Read more

IKARIA^® TO PRESENT AT STIFEL NICOLAUS 2011 HEALTHCARE CONFERENCE

August 31, 2011 Read more

IKARIA^® TO PRESENT AT 2011 WEDBUSH LIFE SCIENCES MANAGEMENT ACCESS CONFERENCE

August 9, 2011 Read more

FDA CLEARS EXPANDED COMPATIBILITY FOR INOMAX DRUG-DELIVERY SYSTEMS
-- INOMAX^® DS and INOMAX^® DSIR NOW COMPATIBLE WITH 51 RESPIRATORY CARE DEVICES --

August 1, 2011 Read more

IKARIA^® CEO DANIEL TASSÉ ELECTED TO HEALTH SECTION OF BIO'S BOARD OF DIRECTORS

June 28, 2011 Read more

IKARIA^® TO PRESENT AT 2011 BIO BUSINESS FORUM AND INTERNATIONAL CONVENTION

June 21, 2011 Read more

IKARIA^® LAUNCHES NEXT-GENERATION DRUG-DELIVERY SYSTEM

April 11, 2011 Read more

IKARIA^® INTRODUCES NEXT-GENERATION INOMAX^® DRUG-DELIVERY SYSTEM IN AUSTRALIA

March 23, 2011 Read more

IKARIA^® TO PRESENT AT 31st ANNUAL COWEN AND COMPANY HEALTHCARE CONFERENCE

March 2, 2011 Read more

IKARIA^® INTRODUCES NEXT-GENERATION DRUG-DELIVERY SYSTEM IN CANADA

February 22, 2011 Read more

FDA EXTENDS MARKETING EXCLUSIVITY FOR INOMAX^®

January 5, 2011 Read more

IKARIA^® BEGINS ENROLLMENT OF PIVOTAL TRIAL FOR LUCASSIN^®

November 30, 2010 Read more

IKARIA^® RECALLS INOMAX^® DS DRUG-DELIVERY SYSTEM

August 9, 2010 Read more

IKARIA^® NAMES CHIEF SCIENCE OFFICER

July 15, 2010 Read more

IKARIA^® NAMES NEW CHIEF FINANCIAL OFFICER

July 8, 2010 Read more

IKARIA^® APPOINTS CHIEF MEDICAL OFFICER

June 8, 2010 Read more

IKARIA^® NAMES NEW HEAD OF RESEARCH & DEVELOPMENT

June 1, 2010 Read more

IKARIA^® ANNOUNCES ELECTION OF HOWARD H. PIEN TO BOARD OF DIRECTORS

April 14, 2010 Read more

IKARIA^® ACQUIRES NEW DRUG APPLICATION FOR LUCASSIN^®

March 30, 2010 Read more

$2.5 MILLION GIFT AIMS TO HELP CHILDREN SURVIVE AND THRIVE

March 24, 2010 Read more

IKARIA^® RECEIVES AWARD FOR EXCELLENCE BY NEW JERSEY BUSINESS & INDUSTRY ASSOCIATION

October 21, 2009 Read more

IKARIA^® NAMES NEW CHAIRMAN

October 19, 2009 Read more

IKARIA^® TO IN-LICENSE WORLDWIDE RIGHTS TO INVESTIGATIONAL PORTFOLIO FROM FIBREX MEDICAL

August 10, 2009 Read more

IKARIA^® TO IN-LICENSE BIOLINERx'S BL-1040

July 6, 2009 Read more

FDA ACCEPTS FINAL SECTION OF NDA FILING FOR LUCASSIN^®

Jun 12, 2009 Read more

IKARIA^® TO PRESENT AT 27th ANNUAL JPMORGAN HEALTHCARE CONFERENCE

Jan 8, 2009 Read more

IKARIA^® NAMED PRIVATE COMPANY OF THE YEAR BY NEW JERSEY TECHNOLOGY COUNCIL

Nov 21, 2008 Read more

INHALED NITRIC OXIDE DATA PRESENTED AT EUROPEAN ACADEMY OF PEDIATRICS MEETING

Oct 25, 2008 Read more

IKARIA^® STRENGTHENS EXECUTIVE LEADERSHIP TEAM
Head of Engineering and Operations Appointed.

Oct 2, 2008 Read more

IKARIA^® ACQUIRES NORTH AMERICAN RIGHTS TO LUCASSIN^® FROM ORPHAN THERAPEUTICS
No Currently Approved Drugs to Treat Hepatorenal Syndrome Type 1 in U.S.

Sept. 2, 2008 Read more

IKARIA^® STRENGTHENS COMMERCIAL OPERATIONS AND HUMAN RESOURCES LEADERSHIP
Appoints Stephen Ross Senior Vice President of Commercial Operations and James Briggs Senior Vice President of Human Resources.

Aug. 25, 2008 Read more

IKARIA^® RECEIVES FDA ORPHAN DRUG DESIGNATION FOR INHALED CARBON MONOXIDE FOR DELAYED GRAFT FUNCTION IN SOLID ORGAN TRANSPLANTS

July 28, 2008 Read more

IKARIA'S INOFLO (NITRIC OXIDE) FOR INHALATION APPROVED IN JAPAN
Ikaria to Market and Distribute INOflo via Partnership with Air Water Incorporated and Sumitomo Seika Chemicals

July 21, 2008 Read more

IKARIA^® STRENGTHENS RESEARCH & DEVELOPMENT TEAM
Appoints Dr. Deborah Petrowsky Vice President of Medical Affairs and Dr. Steven Knapp Vice President of Regulatory Affairs

July 1, 2008 Read more

IKARIA^® INTRODUCES DR. MICHAEL COOREMAN AS VICE PRESIDENT OF TRANSLATIONAL MEDICINE
Translational Medicine Department Strengthens Research & Development Team

June 24, 2008 Read more

IKARIA^'S INOFLO (NITRIC OXIDE) FOR INHALATION TO BE OFFICIALLY APPROVED IN JAPAN

June 18, 2008 Read more

IKARIA^® COMPLETES DOSING OF PHASE 1A CLINICAL STUDY FOR IK-1001 (SODIUM SULFIDE) FOR INJECTION

May 19, 2008 Read more

LOTA ZOTH ELECTED TO IKARIA^® BOARD AND NAMED AUDIT COMMITTEE CHAIR

Jan. 22, 2008 Read more

IKARIA^® WINS SECOND CONSECUTIVE AARC ZENITH AWARD
at 53rd International Respiratory Congress

Jan. 17, 2008 Read more

IKARIA^® APPOINTS DANIEL TASSÉ AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
Former CEO David Shaw Named Executive Chairman and Chairman of the Board.

Jan. 9, 2008 Read more

IKARIA^® TO PRESENT AT 26th ANNUAL JPMORGAN HEALTHCARE CONFERENCE

Jan. 3, 2008 Read more

IKARIA'S INOMAX (NITRIC OXIDE) FOR INHALATION APPROVED IN AUSTRALIA
Expands global reach of Ikaria with approval of first pharmaceutical gas in Australia to help newborns who suffer from hypoxic respiratory failure.

November 27, 2007 Read more

IKARIA^® NAMES EXECUTIVE VICE PRESIDENT OF RESEARCH AND DEVELOPMENT

October 1, 2007 Read more

IKARIA^® FOUNDING SCIENTIST NAMED 2007 MACARTHUR FELLOW

September, 26, 2007 Read more

NEW STUDY SHOWS PROMISE FOR HYDROGEN SULFIDE IN REDUCING HEART-ATTACK DAMAGE, IKARIA^® ANNOUNCES Study led by Albert Einstein College of Medicine researchers published in major scientific journal

September 25, 2007 Read more

MATTHEW BENNETT JOINS IKARIA^® AS VICE PRESIDENT AND GENERAL COUNSEL

July 23, 2007 Read more

DAVID SHAW TO SERVE AS PRESIDENT OF IKARIA^® AND INO THERAPEUTICS

May 2, 2007 Read more

IKARIA^® AND INVESTOR GROUP CLOSE TRANSACTION TO ACQUIRE INO THERAPEUTICS FROM LINDE IN $670 MILLION CASH AND STOCK MERGER, CREATING A WORLD LEADER IN CRITICAL CARE THERAPEUTICS

March 28, 2007 Read more

IKARIA^® ANNOUNCES IN-LICENSING OF "THYRONAMINE TECHNOLOGY" FROM THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO AND OREGON HEALTH & SCIENCE UNIVERSITY

February 25, 2007 Read more

INO THERAPEUTICS WINS ZENITH AWARD

December, 2006 Read more